Press Releases

10.31.2018
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)
10.31.2018
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
10.23.2018
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018
10.04.2018
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
10.03.2018
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference
08.22.2018
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences
08.01.2018
Ophthotech Reports Second Quarter 2018 Financial and Operating Results
07.25.2018
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018
06.07.2018
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania
05.09.2018
Ophthotech Reports First Quarter 2018 Financial and Operating Results